Lymphoma Trial, Recruiting NCT07422337 Sponsor: Arkansas Children's Hospital Research Institute Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07422337
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You or your child must have been diagnosed with a specific type of blood cancer called B-cell acute lymphoblastic leukemia or lymphoma
  • You or your child must have been between 1 year old and 21 years old at the time of diagnosis
  • You or your child (and parent/guardian if applicable) must be willing and able to give consent to take part in the trial
  • You or your child must have received all the standard vaccinations that are normally given during the first year of life

Who may not be able to join:

  • People whose cancer has come back or has not responded to treatment at any point
  • People who have had, or who will need, a bone marrow transplant or a similar cell-based treatment
  • People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lauren Appell, MD, Arkansas Children's Research Institute

Phone: 501-364-1494

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Arkansas Children's Hospital Research Institute
Registry
ClinicalTrials.gov
Start date
13 January 2026
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of participants with protective serum antibody titers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov